deltatrials
Terminated NA INTERVENTIONAL 2-arm NCT00737724

Simultaneous Versus Sequential Antiretroviral Therapy (ARV) Therapy and Mycobacterium Tuberculosis (MTB) Treatment

Efficacy of Simultaneous Versus Sequential Antiretroviral Therapy and Antituberculosis Treatment in Patients With AIDS and Active Tuberculosis. Open, Randomized and Controlled, Multisite Clinical Trial.

Sponsor: Consorcio de Investigación sobre VIH/SIDA/TB (CISIDAT).

Conditions AIDS HIV Tuberculosis
Interventions Deferred RV and antiMTB treatment Simultaneous ARV and antiMTB
Updated 6 times since 2017 Last updated: Mar 24, 2015 Started: Mar 31, 2008 Primary completion: Feb 28, 2011 Completion: Feb 28, 2011
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Other published trials showed definitive expected superiority of Group 1

Other AIDS trials with similar outcome

Browse all AIDS trials

This NA trial investigates AIDS and HIV and is currently terminated or withdrawn. Consorcio de Investigación sobre VIH/SIDA/TB (CISIDAT). leads this study, which shows 6 recorded versions since 2008 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotTerminated~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotTerminated~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotTerminated~Sep 2025 – present · 10 months · monthly snapshotTerminated

Change History

6 versions recorded

  1. Sep 2025 — Present [monthly]

    Terminated NA

  2. Sep 2024 — Sep 2025 [monthly]

    Terminated NA

  3. Jul 2024 — Sep 2024 [monthly]

    Terminated NA

  4. Jan 2021 — Jul 2024 [monthly]

    Terminated NA

  5. Jun 2018 — Jan 2021 [monthly]

    Terminated NA

▶ Show 1 earlier version

  1. Jan 2017 — Jun 2018 [monthly]

    Terminated NA

    First recorded

Mar 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Consorcio de Investigación sobre VIH/SIDA/TB (CISIDAT).
  • Instituto Nacional de Enfermedades Respiratorias
Data source: Instituto Nacional de Enfermedades Respiratorias

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations